Status:
COMPLETED
An Intervention Study To Improve Human PapillomaVirus ( HPV) Immunization in Haitian and African American Girls
Lead Sponsor:
Boston Medical Center
Conditions:
Cervical Cancer
Eligibility:
FEMALE
11-15 years
Phase:
NA
Brief Summary
In the United States, Black women are more likely to die of cervical cancer than White women. In developing countries and globally, Haitian immigrant women are more likely to die of cervical cancer th...
Detailed Description
In the U.S., Black women have higher rates of cervical cancer than White women. Women in Haiti and Haitian immigrant women have among the highest rates of cervical cancer in the world. The recent intr...
Eligibility Criteria
Inclusion
- 11-15 HPV vaccine eligible adolescent girls
Exclusion
- Prior receipt of the HPV vaccine
- pregnant
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01254669
Start Date
January 1 2011
End Date
March 1 2014
Last Update
May 19 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02118